What is the appropriate management for a patient with a hyperdense middle cerebral artery (MCA) sign on non‑contrast CT?

Management of Hyperdense MCA Sign on Non-Contrast CT

A patient with hyperdense MCA sign on non-contrast CT should receive immediate intravenous thrombolysis (if within the treatment window and no contraindications exist) followed by urgent endovascular thrombectomy, as the hyperdense sign indicates large vessel occlusion requiring aggressive recanalization therapy. 1

Immediate Assessment and Imaging

• Confirm the diagnosis with CT angiography of the head and neck to document the MCA occlusion location (proximal M1 vs distal M2 segment), as this determines prognosis and treatment approach 1
• The hyperdense MCA sign indicates acute thrombus within the vessel and is associated with large vessel occlusion requiring urgent intervention 1, 2
• Do not delay treatment based on the presence of hyperdense MCA sign alone—this finding should NOT be used as a criterion to withhold IV thrombolysis from otherwise eligible patients 1
• Obtain baseline NIHSS score and ASPECTS score on non-contrast CT to assess stroke severity and extent of early ischemic changes 1

Thrombolytic Therapy Decision

Administer IV alteplase (0.9 mg/kg, maximum 90 mg) immediately if the patient presents within 4.5 hours of symptom onset and has no contraindications 1, 3:

• Give 10% as IV bolus over 1 minute, then 90% as infusion over 60 minutes 1
• Randomized trial data from NINDS rtPA and IST-3 demonstrate no statistically significant deleterious interaction between alteplase treatment and hyperdense MCA sign on clinical outcomes 1
• Patients with hyperdense MCA sign who received IV rtPA did not fare worse at 3 months despite having more severe strokes on average 4

Critical contraindications to verify before thrombolysis 3:

• Blood pressure must be <185/110 mmHg before treatment
• No intracranial hemorrhage on CT
• Platelet count ≥100,000/mm³ and INR ≤1.7
• No prior intracranial hemorrhage or recent stroke within 3 months

Endovascular Thrombectomy

Proceed urgently to mechanical thrombectomy regardless of IV tPA administration 1:

• Endovascular therapy is indicated for patients with large vessel occlusion who can be treated within 6 hours (groin puncture within 6 hours of symptom onset) 1
• Do not wait to assess IV tPA response—initiate IV tPA while simultaneously preparing the angiography suite for thrombectomy 1
• Retrievable stents are the first-choice endovascular device 1
• Target time from CT to groin puncture should be <60 minutes 1

The hyperdense MCA sign predicts favorable response to mechanical thrombectomy 5:

• Patients with hyperdense sign have significantly higher successful recanalization rates (92.1% vs 74.5% without the sign) 5
• Better clinical outcomes occur with thrombectomy in hyperdense sign patients (54.3% vs 37.3% favorable outcome at 3 months) 5
• Lower rates of symptomatic intracranial hemorrhage (2.9% vs 17.6%) 5

Location-Specific Considerations

Proximal vs distal hyperdense sign matters for prognosis 6:

• Proximal hyperdense MCA sign (M1 segment) indicates worse prognosis with IV tPA alone and stronger indication for immediate thrombectomy 6
• Patients with proximal hyperdense sign are less likely to have rapid neurological recovery with IV tPA compared to distal sign 6
• Proximal hyperdense sign is independently associated with higher risk of asymptomatic hemorrhagic transformation after thrombectomy 7
• Distal hyperdense sign (M2 segment) has similar outcomes to patients without hyperdense sign when treated with IV tPA 6

Post-Treatment Monitoring

Intensive monitoring protocol 1:

• Blood pressure checks every 15 minutes during and for 2 hours after IV tPA, then every 30 minutes for 6 hours, then hourly until 24 hours 1
• Maintain blood pressure ≤180/105 mmHg for 24 hours post-treatment 1, 3
• Neurological assessments at same intervals as blood pressure monitoring 1
• If severe headache, acute hypertension, nausea, vomiting, or neurological worsening occurs, discontinue tPA infusion and obtain emergent CT 1

Follow-up imaging 1:

• Obtain CT or MRI at 24 hours after IV tPA before starting anticoagulants or antiplatelet agents 1
• Monitor for hemorrhagic transformation, which occurs more frequently with large infarcts and reperfusion 8

Management of Cerebral Edema Risk

The hyperdense MCA sign with large territory involvement predicts malignant cerebral edema 8:

• Brain swelling causes approximately one-third of deterioration cases in MCA territory infarctions 8
• Early CT hypodensity >50% of MCA territory within 12 hours predicts neurological deterioration 8
• Elevate head of bed to 20-30 degrees to facilitate venous drainage 8
• Restrict free water to avoid hypo-osmolar fluids that worsen edema 8
• Consider osmotic therapy (mannitol or hypertonic saline) for clinical deterioration from cerebral swelling 8
• Decompressive hemicraniectomy should be considered for malignant MCA infarction, particularly within 48 hours of stroke onset and before severe neurological deterioration, as it reduces mortality by approximately 50% in patients ≤60 years 8

Critical Pitfalls to Avoid

• Do not withhold IV tPA based solely on the presence of hyperdense MCA sign—this is explicitly stated as NOT a contraindication 1
• Do not delay endovascular therapy to wait for IV tPA response—both should proceed simultaneously 1
• Do not assume poor prognosis—hyperdense sign actually predicts better thrombectomy outcomes due to higher recanalization rates 5
• Do not proceed directly to angiography without first excluding intracranial hemorrhage on non-contrast CT 1, 3
• In select cases with clear LVO etiology (e.g., new atrial fibrillation) and hyperdense MCA sign, proceeding directly to catheter angiography after non-contrast CT may be considered to minimize time to thrombectomy 1